Colgate-Palmolive (NYSE:CL) Shares Bought by Palisade Asset Management LLC

Palisade Asset Management LLC lifted its stake in shares of Colgate-Palmolive (NYSE:CL) by 5.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 122,804 shares of the company’s stock after purchasing an additional 6,772 shares during the quarter. Palisade Asset Management LLC’s holdings in Colgate-Palmolive were worth $9,789,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Colgate-Palmolive by 2.2% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 253,749 shares of the company’s stock valued at $18,044,000 after buying an additional 5,445 shares during the period. Farmers & Merchants Investments Inc. lifted its holdings in Colgate-Palmolive by 1.2% in the third quarter. Farmers & Merchants Investments Inc. now owns 38,500 shares of the company’s stock valued at $2,738,000 after acquiring an additional 463 shares during the period. Brighton Jones LLC lifted its holdings in Colgate-Palmolive by 5.7% in the third quarter. Brighton Jones LLC now owns 6,864 shares of the company’s stock valued at $488,000 after acquiring an additional 373 shares during the period. IFM Investors Pty Ltd boosted its position in shares of Colgate-Palmolive by 3.4% during the 3rd quarter. IFM Investors Pty Ltd now owns 165,499 shares of the company’s stock worth $11,769,000 after purchasing an additional 5,493 shares in the last quarter. Finally, Waldron Private Wealth LLC increased its holdings in shares of Colgate-Palmolive by 2.7% in the 3rd quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock valued at $381,000 after purchasing an additional 140 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on CL. Evercore ISI boosted their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a report on Monday, April 8th. Wells Fargo & Company boosted their target price on Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a research report on Monday, April 29th. The Goldman Sachs Group started coverage on Colgate-Palmolive in a research report on Friday, March 1st. They issued a “buy” rating and a $93.00 price target for the company. UBS Group boosted their price objective on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 29th. Finally, Bank of America raised their target price on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday, April 29th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $91.44.

Insiders Place Their Bets

In related news, insider Jennifer Daniels sold 5,790 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $83.96, for a total value of $486,128.40. Following the transaction, the insider now owns 63,236 shares in the company, valued at $5,309,294.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares in the company, valued at $22,797,983.85. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Jennifer Daniels sold 5,790 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $83.96, for a total value of $486,128.40. Following the transaction, the insider now directly owns 63,236 shares in the company, valued at $5,309,294.56. The disclosure for this sale can be found here. Insiders sold 159,048 shares of company stock worth $13,336,846 over the last three months. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Trading Down 0.6 %

Colgate-Palmolive stock traded down $0.61 during trading on Wednesday, hitting $93.47. The company’s stock had a trading volume of 7,224,209 shares, compared to its average volume of 4,672,649. The stock’s fifty day moving average is $88.64 and its 200 day moving average is $82.63. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $94.40. The stock has a market capitalization of $76.69 billion, a price-to-earnings ratio of 29.77, a P/E/G ratio of 3.43 and a beta of 0.40. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same period in the prior year, the firm posted $0.73 EPS. The company’s revenue was up 6.2% on a year-over-year basis. As a group, equities research analysts predict that Colgate-Palmolive will post 3.52 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.14%. The ex-dividend date is Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s payout ratio is 63.29%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.